Business Brief -- Genzyme Corp.:
   IG Labs Pays Cash, Stock
   To Purchase Genetic Design
IG Labs will keep $5 million for working capital and use
$6 million to pay some Genetic Design debt, making the
effective purchase price of Genetic Design about $29.3
million.
   Genzyme said the combined businesses of IG Labs and
Genetic Design should generate revenue of $30 million in
1992.
   After the exchange of shares involved in the transaction,
Genzyme's ownership in IG Labs will increase to 68% from 56%.